Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]
Titel:
Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]
Auteur:
Mischoulon, D. Hylek, L. Yeung, A.S. Clain, A.J. Baer, L. Cusin, C. Ionescu, D.F. Alpert, J.E. Soskin, D.P. Fava, M.